Search Results

There are 7340378 results for: content related to: Reversible hyperkinetic movement disorder associated with quetiapine withdrawal

  1. A Literature Review of Quetiapine for Generalized Anxiety Disorder

    Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy

    Volume 35, Issue 2, February 2015, Pages: 175–188, Tiffany-Jade M. Kreys and Stephanie V. Phan

    Version of Record online : 17 FEB 2015, DOI: 10.1002/phar.1529

  2. You have free access to this content
    Quetiapine versus other atypical antipsychotics for schizophrenia

    Intervention Review

    The Cochrane Library

    Laila Asmal, Srnka J Flegar, Jikun Wang, Christine Rummel-Kluge, Katja Komossa and Stefan Leucht

    Published Online : 18 NOV 2013, DOI: 10.1002/14651858.CD006625.pub3

  3. You have full text access to this OnlineOpen article
    A retrospective study of clinical usage of quetiapine XR and quetiapine IR in outpatients with schizophrenia in Denmark

    Human Psychopharmacology: Clinical and Experimental

    Volume 27, Issue 5, September 2012, Pages: 492–498, Charlotte Emborg, Teresa Hallerbäck, Leif Jörgensen and Andreas Carlborg

    Version of Record online : 20 SEP 2012, DOI: 10.1002/hup.2254

  4. A randomized, placebo- and active-controlled study of paliperidone extended release for the treatment of acute manic and mixed episodes of bipolar I disorder

    Bipolar Disorders

    Volume 12, Issue 3, May 2010, Pages: 230–243, Eduard Vieta, Isaac F Nuamah, Pilar Lim, Eric C Yuen, Joseph M Palumbo, David W Hough and Joris Berwaerts

    Version of Record online : 10 MAY 2010, DOI: 10.1111/j.1399-5618.2010.00815.x

  5. Quetiapine for schizophrenia

    Intervention Review

    The Cochrane Library

    Manit Srisurapanont, Benchalak Maneeton, Narong Maneeton, Sudheer Lankappa and Rahul Gandhi

    Published Online : 19 APR 2004, DOI: 10.1002/14651858.CD000967.pub2

  6. Investigation of a Possible Interaction Between Quetiapine and Armodafinil in Patients With Schizophrenia: An Open-Label, Multiple-Dose Study

    The Journal of Clinical Pharmacology

    Volume 52, Issue 9, September 2012, Pages: 1399–1409, Mona Darwish, Mary Bond, Edward T. Hellriegel, James M. Youakim, Ronghua Yang and Philmore Robertson Jr

    Version of Record online : 7 MAR 2013, DOI: 10.1177/0091270011414572

  7. Early-onset tardive dyskinesia in a neuroleptic-naive patient exposed to low-dose quetiapine

    Movement Disorders

    Volume 26, Issue 12, October 2011, Pages: 2297–2298, Richard A. Walsh and Anthony E. Lang

    Version of Record online : 6 JUL 2011, DOI: 10.1002/mds.23831

  8. You have free access to this content
    Interactions between valproic acid and quetiapine/olanzapine in the treatment of bipolar disorder and the role of therapeutic drug monitoring

    Journal of Pharmacy and Pharmacology

    Volume 66, Issue 6, June 2014, Pages: 747–759, Thomas Vella and Janet Mifsud

    Version of Record online : 7 JAN 2014, DOI: 10.1111/jphp.12209

  9. Reversible withdrawal dyskinesia associated with quetiapine

    Movement Disorders

    Volume 20, Issue 6, June 2005, Pages: 769–770, Costas Michaelides, Manisha Thakore-James and Raymon Durso

    Version of Record online : 3 MAR 2005, DOI: 10.1002/mds.20427

  10. Tolerability of extended-release quetiapine fumarate compared with immediate-release quetiapine fumarate in older patients with Alzheimer's disease with symptoms of psychosis and/or agitation: a randomised, double-blind, parallel-group study

    International Journal of Geriatric Psychiatry

    Volume 27, Issue 3, March 2012, Pages: 296–304, Peter Paul De Deyn, Hans Eriksson, Hanna Svensson and on behalf of the Study 115 investigators

    Version of Record online : 27 APR 2011, DOI: 10.1002/gps.2720

  11. Quetiapine in Bipolar Disorder

    Bipolar Psychopharmacotherapy: Caring for the Patient, Second Edition

    Mauricio Kunz, Svante Nyberg, Lakshmi N. Yatham, Pages: 193–222, 2011

    Published Online : 13 APR 2011, DOI: 10.1002/9780470975114.ch10

  12. Quetiapine: An alternative treatment in painless legs and moving toes

    Movement Disorders

    Volume 23, Issue 9, 15 July 2008, Pages: 1326–1328, Roberto Di Fabio, Carlo Casali and Francesco Pierelli

    Version of Record online : 28 APR 2008, DOI: 10.1002/mds.22047

  13. Second-generation antipsychotics for major depressive disorder and dysthymia

    Intervention Review

    The Cochrane Library

    Katja Komossa, Anna M Depping, Andrea Gaudchau, Werner Kissling and Stefan Leucht

    Published Online : 8 DEC 2010, DOI: 10.1002/14651858.CD008121.pub2

  14. Trends in quetiapine use and non-fatal quetiapine-related ambulance attendances

    Drug and Alcohol Review

    Volume 32, Issue 4, July 2013, Pages: 405–411, Cherie Heilbronn, Belinda Lloyd, Paul McElwee, Alan Eade and Dan I. Lubman

    Version of Record online : 27 JAN 2013, DOI: 10.1111/dar.12028

  15. You have free access to this content
    Quetiapine versus typical antipsychotic medications for schizophrenia

    Intervention Review

    The Cochrane Library

    Sirijit Suttajit, Manit Srisurapanont, Jun Xia, Siritree Suttajit, Benchalak Maneeton and Narong Maneeton

    Published Online : 31 MAY 2013, DOI: 10.1002/14651858.CD007815.pub2

  16. Prevalence and associations of quetiapine fumarate misuse among an Australian national city sample of people who regularly inject drugs


    Volume 109, Issue 2, February 2014, Pages: 295–302, Siobhan Emma Reddel, Raimondo Bruno, Lucy Burns, Amy Kirwan, Kamalini Lokuge and Paul Dietze

    Version of Record online : 25 NOV 2013, DOI: 10.1111/add.12395

  17. Second-generation antipsychotics for anxiety disorders

    Intervention Review

    The Cochrane Library

    Anna M Depping, Katja Komossa, Werner Kissling and Stefan Leucht

    Published Online : 8 DEC 2010, DOI: 10.1002/14651858.CD008120.pub2

  18. You have free access to this content
    Chlorpromazine versus atypical antipsychotic drugs for schizophrenia

    Intervention Review

    The Cochrane Library

    Kumar B Saha, Li Bo, Sai Zhao, Jun Xia, Stephanie Sampson and Rashid U Zaman

    Published Online : 5 APR 2016, DOI: 10.1002/14651858.CD010631.pub2

  19. Population pharmacokinetic modeling of quetiapine after administration of seroquel and seroquel XR formulations to Western and Chinese patients with schizophrenia, schizoaffective disorder, or bipolar disorder

    The Journal of Clinical Pharmacology

    Volume 55, Issue 11, November 2015, Pages: 1248–1255, Diansong Zhou, Khanh H. Bui, Jianguo Li and Nidal Al-Huniti

    Version of Record online : 14 JUL 2015, DOI: 10.1002/jcph.544

  20. You have free access to this content
    Effects of cytochrome P450 3A modulators ketoconazole and carbamazepine on quetiapine pharmacokinetics

    British Journal of Clinical Pharmacology

    Volume 61, Issue 1, January 2006, Pages: 58–69, Scott W. Grimm, Neil M. Richtand, Helen R. Winter, Karen R. Stams and Stots B. Reele

    Version of Record online : 29 SEP 2005, DOI: 10.1111/j.1365-2125.2005.02507.x